Test Price
2,800 AED✅ Home Collection Available
CHRNE Gene Congenital Myasthenic Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed Lab
Executive Summary & Core Metrics
- Accuracy: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited Next‑Generation Sequencing (NGS).
- Logistics: VIP Mobile Phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM. Secure courier retrieval for archival tissue specimens only if applicable.
- Post‑Test Support: Telephonic clinical guidance for result interpretation from a Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- DHA Licensed Facility: License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Test Overview & Methodology
The CHRNE gene test uses Next‑Generation Sequencing (NGS) to precisely identify pathogenic variants associated with congenital myasthenic syndrome (CMS). This single‑gene analysis provides full coverage of coding exons, flanking intronic regions, and splice sites, enabling definitive diagnosis and tailored management. Results are correlated with clinical presentation and family history to guide treatment and genetic counselling.
Our NGS vs. Conventional Sanger Sequencing
| Feature | Our NGS Test | Single‑Gene Sanger Sequencing |
|---|---|---|
| Method | NGS – full gene coverage including deep intronic regions | Limited to exonic hotspots |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Cost | 2,800 AED | ~3,500 AED |
| Regulatory Compliance | ISO 9001:2015, DHA/MOHAP standards | Variable |
Physician Insight & Safety Protocols
Ms. Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA ID: 9294403 – “This targeted genetic test uncovers the molecular basis of congenital myasthenic syndrome with high precision. However, results must be interpreted alongside the patient’s clinical history and electrophysiological findings. Our team provides pre‑test counselling and post‑result guidance to ensure informed decision‑making and appropriate management.”
Medication Advisory
Do not discontinue any prescribed medication—particularly pyridostigmine or other anticholinesterase agents—without consulting your physician. Sudden withdrawal can worsen muscle weakness and lead to respiratory compromise. Always discuss test results with your treating neurologist before adjusting therapy.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent (unless legal guardian present), acute febrile illness, or bleeding disorder that contraindicates phlebotomy.
- Emergency Red Flags: Sudden worsening of muscle weakness, difficulty swallowing with choking, respiratory distress, cyanosis, or severe bulbar symptoms. If these occur, seek immediate care at the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the CHRNE gene test for?
This genetic test detects CHRNE gene mutations that cause congenital myasthenic syndrome (CMS). It helps confirm the diagnosis, guide treatment (e.g., response to anticholinesterase therapy), and inform family planning.
2. How is the sample collected?
For standard whole‑blood or buccal swab specimens, our certified team performs a brief, minimally invasive collection at your home using VIP Mobile Phlebotomy. The sample is transported under temperature‑controlled cold chain to our ISO‑accredited laboratory.
3. Does insurance cover the 2,800 AED cost?
We offer direct billing verification via WhatsApp (+971 54 548 8731) to check your insurance coverage. Many UAE health plans cover genetic testing for inherited neuromuscular disorders with prior approval.
4. How long do results take?
The turnaround time is 3–4 weeks from sample receipt. Urgent cases may be expedited upon request. You will receive a detailed report and a telephonic consultation with our geneticist.
5. Can the test be performed during pregnancy?
Yes, for at‑risk foetuses via chorionic villus sampling or amniocentesis, provided the family has previously identified pathogenic variants. This requires a specialist referral and is performed only in hospital settings.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and sharing of genetic and health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure electronic health records and telemedicine practices.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – governing clinical safety, informed consent, and patient rights.
All genetic data is encrypted, access‑controlled, and retained only as long as required by UAE regulatory standards. Results are shared only with the patient and their authorised physician.
Clinical & Logistical Metadata
| Test Name | CHRNE Gene Congenital Myasthenic Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or buccal swab; VIP Mobile Phlebotomy home collection available |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene analysis |
| ICD‑10‑CM Code | G70.2 (Congenital myasthenic syndromes) |
| LOINC Code | 82318-0 (CHRNE gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians